Health ❯ Cancer ❯ Cancer Treatment

Immunotherapy

Checkpoint Inhibitors Immune Checkpoint Inhibitors T Cell Therapy mRNA-based Cancer Vaccines Dendritic Cells Antibody Therapy T Cells Chimeric Antigen Receptor Therapy Clinical Trials Patient Experiences Sucralose Effects mRNA Therapies CD8+ T Cells Regulatory Mechanisms Peptide Therapies Regulatory T Cells in Cancer Cancer Cells Dietary Interventions Therapeutic Strategies Cancer Immunotherapy Circadian Rhythms CD27 Receptors Novel Therapeutics Next-Generation Therapies Personalized Medicine Metastasis Prevention

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

The four-pronged design clusters CD27 receptors to boost T‑cell activation in preclinical tests.

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Unified Model Reveals How Antimicrobial Peptides Form Transient Pores to Kill Bacteria

Studies Show Lymph Nodes Sustain Stem-Like T Cells That Power Cancer Immunotherapy

Eye-Health Nutrient Zeaxanthin Boosts T Cells in Preclinical Cancer Study

T Cells Convert Sugar Into Lipid Rafts to Amplify Tumor-Fighting Signals

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

Coordinated Loss of the Y Chromosome in Tumors Linked to Poor Cancer Survival

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer